This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Infex Therapeutics Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kevin Blades: Innovator in Antibacterial Compounds
Introduction
Kevin Blades is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating bacterial infections. His innovative work focuses on enhancing the efficacy of antibacterial agents.
Latest Patents
Kevin Blades holds 1 patent for his invention titled "Synthesis of pyrrole acid derivatives." This invention pertains to the synthesis of compounds that can be utilized in conjunction with other antibacterial agents, specifically a class known as carbapenems. The compounds produced through his novel methods serve as enzyme inhibitors, particularly targeting metallo-β-lactamase enzymes.
Career Highlights
Throughout his career, Kevin has been associated with Infex Therapeutics Limited, where he has played a crucial role in advancing research and development in antibacterial therapies. His work has been instrumental in addressing the growing concern of antibiotic resistance.
Collaborations
Kevin collaborates with esteemed colleagues, including Andrew Wilkinson and Ian Cooper, who contribute to the innovative environment at Infex Therapeutics Limited.
Conclusion
Kevin Blades is a dedicated inventor whose work in synthesizing antibacterial compounds is paving the way for new treatments against bacterial infections. His contributions are vital in the ongoing battle against antibiotic resistance.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile